Shariah compliance overview
Not HalalAardvark Therapeutics, Inc. Common Stock (AARD) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Aardvark Therapeutics, Inc. Common Stock
Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders.
Aardvark Therapeutics, Inc. Common Stock (AARD) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.
- Business Activity
- 100.00%Limit 5%Fail
- Interest-bearing debt
- 0.00%Limit 30%Pass
- Interest-bearing securities and assets
- 42.86%Limit 30%Fail
- Dividend purification
- 100.00%Share of dividends to give to charityPurification calculator
Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Aardvark Therapeutics, Inc. Common Stock (AARD). Current Akinda screening label: Not Halal.
